477 related articles for article (PubMed ID: 15582691)
41. Construction and characterization of E3-deleted bovine adenovirus type 3 expressing full-length and truncated form of bovine herpesvirus type 1 glycoprotein gD.
Zakhartchouk AN; Reddy PS; Baxi M; Baca-Estrada ME; Mehtali M; Babiuk LA; Tikoo SK
Virology; 1998 Oct; 250(1):220-9. PubMed ID: 9770436
[TBL] [Abstract][Full Text] [Related]
42. A live bovine herpesvirus-1 marker vaccine is not shed after intramuscular vaccination.
Makoschey B; Beer M
Berl Munch Tierarztl Wochenschr; 2007; 120(11-12):480-2. PubMed ID: 18085158
[TBL] [Abstract][Full Text] [Related]
43. BHV-1 vaccine induces cross-protection against BHV-5 disease in cattle.
Del Médico Zajac MP; Puntel M; Zamorano PI; Sadir AM; Romera SA
Res Vet Sci; 2006 Dec; 81(3):327-34. PubMed ID: 16540133
[TBL] [Abstract][Full Text] [Related]
44. Bovine herpesvirus type 1 (BHV-1) mutant lacking U(L)49.5 luminal domain residues 30-32 and cytoplasmic tail residues 80-96 induces more rapid onset of virus neutralizing antibody and cellular immune responses in calves than the wild-type strain Cooper.
Wei H; He J; Paulsen DB; Chowdhury SI
Vet Immunol Immunopathol; 2012 Jun; 147(3-4):223-9. PubMed ID: 22578851
[TBL] [Abstract][Full Text] [Related]
45. Cell-mediated immune responses induced by BHV-1: rational vaccine design.
van Drunen Littel-van den Hurk S
Expert Rev Vaccines; 2007 Jun; 6(3):369-80. PubMed ID: 17542752
[TBL] [Abstract][Full Text] [Related]
46. Coexpression of interleukin-2 enhances the immunization effect of a DNA vaccine expressing herpes simplex 1 glycoprotein D.
Li WR; Niu B; Wang JW; Feng ZJ; Wang DX
Acta Virol; 2006; 50(4):251-6. PubMed ID: 17177610
[TBL] [Abstract][Full Text] [Related]
47. Construction and characterization of a glycoprotein E gene-deleted bovine herpesvirus type 1 recombinant.
Chowdhury SI; Ross CS; Lee BJ; Hall V; Chu HJ
Am J Vet Res; 1999 Feb; 60(2):227-32. PubMed ID: 10048557
[TBL] [Abstract][Full Text] [Related]
48. Mucosal immunization of calves with recombinant bovine adenovirus-3 coexpressing truncated form of bovine herpesvirus-1 gD and bovine IL-6.
Kumar P; Ayalew LE; Godson DL; Gaba A; Babiuk LA; Tikoo SK
Vaccine; 2014 May; 32(26):3300-6. PubMed ID: 24731813
[TBL] [Abstract][Full Text] [Related]
49. Plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses.
Higgins TJ; Herold KM; Arnold RL; McElhiney SP; Shroff KE; Pachuk CJ
J Infect Dis; 2000 Nov; 182(5):1311-20. PubMed ID: 11023455
[TBL] [Abstract][Full Text] [Related]
50. Protective immunity following vaccination with a recombinant multiple-epitope protein of bovine herpesvirus type I in a rabbit model.
Wen X; Tong X; Wang M; Wang J; Ni H; Ran X
Appl Microbiol Biotechnol; 2020 Apr; 104(7):3011-3023. PubMed ID: 32002602
[TBL] [Abstract][Full Text] [Related]
51. Adjuvant effect of green propolis on humoral immune response of bovines immunized with bovine herpesvirus type 5.
Fischer G; Cleff MB; Dummer LA; Paulino N; Paulino AS; de Oliveira Vilela C; Campos FS; Storch T; D'Avila Vargas G; de Oliveira Hübner S; Vidor T
Vet Immunol Immunopathol; 2007 Mar; 116(1-2):79-84. PubMed ID: 17275918
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of safety and efficacy of DNA vaccines against bovine herpesvirus-1 (BoHV-1) in calves.
Petrini S; Ramadori G; Corradi A; Borghetti P; Lombardi G; Villa R; Bottarelli E; Guercio A; Amici A; Ferrari M
Comp Immunol Microbiol Infect Dis; 2011 Jan; 34(1):3-10. PubMed ID: 19906427
[TBL] [Abstract][Full Text] [Related]
53. A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months.
Tsang C; Babiuk S; van Drunen Littel-van den Hurk S; Babiuk LA; Griebel P
Vaccine; 2007 Jul; 25(30):5485-94. PubMed ID: 17408815
[TBL] [Abstract][Full Text] [Related]
54. A live attenuated glycoprotein E negative bovine herpesvirus 1 vaccine induces a partial cross-protection against caprine herpesvirus 1 infection in goats.
Thiry J; Tempesta M; Camero M; Tarsitano E; Bellacicco AL; Thiry E; Buonavoglia C
Vet Microbiol; 2006 Mar; 113(3-4):303-8. PubMed ID: 16330168
[TBL] [Abstract][Full Text] [Related]
55. A protective effect of epidermal powder immunization in a mouse model of equine herpesvirus-1 infection.
Kondo T; McGregor M; Chu Q; Chen D; Horimoto T; Kawaoka Y
Virology; 2004 Jan; 318(1):414-9. PubMed ID: 14972566
[TBL] [Abstract][Full Text] [Related]
56. A study on latency in calves by five vaccines against bovine herpesvirus-1 infection.
Castrucci G; Frigeri F; Salvatori D; Ferrari M; Dico ML; Rotola A; Sardonini Q; Petrini S; Cassai E
Comp Immunol Microbiol Infect Dis; 2002 Jul; 25(4):205-15. PubMed ID: 12135235
[TBL] [Abstract][Full Text] [Related]
57. [Eradication of BHV-1 in cattle herds in Saxony-Anhalts using a vaccine lacking a marker--report of an experience].
Gehrmann B; Tyrpe A; Körber R
Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):203-7. PubMed ID: 12784553
[TBL] [Abstract][Full Text] [Related]
58. Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein.
Kaur R; Sachdeva G; Vrati S
J Infect Dis; 2002 Jan; 185(1):1-12. PubMed ID: 11756975
[TBL] [Abstract][Full Text] [Related]
59. Purification of phocid herpesvirus type 1 glycoproteins B and D and pilot studies of immunogenicity in mice.
Martina BE; Harder TC; Osterhaus AD
Vaccine; 2006 Jan; 24(1):90-4. PubMed ID: 16310903
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of apoptotic and anti-apoptotic genes on efficacy of DNA vaccine encoding glycoprotein B of Herpes Simplex Virus type 1.
Parsania M; Bamdad T; Hassan ZM; Kheirandish M; Pouriayevali MH; Sari RD; Jamali A
Immunol Lett; 2010 Feb; 128(2):137-42. PubMed ID: 20026118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
